Sunshine Biopharma, Inc. (NASDAQ:SBFM) Sees Large Increase in Short Interest

Sunshine Biopharma, Inc. (NASDAQ:SBFM) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 374,100 shares, a growth of 16.4% from the October 15th total of 321,500 shares. Currently, 18.7% of the company’s stock are sold short. Based on an average daily volume of 180,600 shares, the short-interest ratio is currently 2.1 days.

Sunshine Biopharma Price Performance

Shares of SBFM traded down $0.22 on Friday, hitting $2.35. The company’s stock had a trading volume of 311,442 shares, compared to its average volume of 137,349. The firm’s fifty day moving average price is $2.92 and its 200-day moving average price is $1.72. Sunshine Biopharma has a fifty-two week low of $2.25 and a fifty-two week high of $637.20.

Sunshine Biopharma (NASDAQ:SBFM) last released its quarterly earnings results on Tuesday, November 5th. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of $9.00 by ($9.94). Sunshine Biopharma had a negative net margin of 12.82% and a negative return on equity of 17.89%. The company had revenue of $8.44 million during the quarter.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.